Search

Thermo Fisher Scientific Inc

Затворен

СекторЗдравеопазване

575.5 -0.21

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

562.67

Максимум

577.21

Ключови измерители

By Trading Economics

Приходи

85M

1.7B

Продажби

989M

12B

P/E

Средно за сектора

30.575

64.641

EPS

6.03

Дивидентна доходност

0.15

Марж на печалбата

14.516

Служители

125,000

EBITDA

262M

2.6B

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+6.98% upside

Дивиденти

By Acuity

Дивидентна доходност

Средно за сектора

0.15%

2.31%

Следващи печалби

21.10.2026 г.

Следваща дата на дивидент

15.10.2026 г.

Следваща дата на екс-дивидент

15.09.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

17B

213B

Предишно отваряне

575.71

Предишно затваряне

575.5

Настроения в новините

By Acuity

23%

77%

66 / 340 Класиране в Healthcare

Thermo Fisher Scientific Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

31.07.2026 г., 22:41 ч. UTC

Correlated Moves

Thermo Fisher Scientific Inc. shares are lower in after-market trading, influenced by a broader market decline and rising U.S. Treasury yields amid inflation concerns.

30.07.2026 г., 19:09 ч. UTC

Correlated Moves

Thermo Fisher Scientific Inc shares are lower amid mixed economic data, including rising jobless claims and disappointing Q2 GDP growth.

29.07.2026 г., 23:16 ч. UTC

Thermo Fisher Scientific shares are trading roughly flat in after-market hours. The stock remains above its 20-day moving average and near its one-month range.

28.07.2026 г., 18:06 ч. UTC

News
Social Media

Thermo Fisher Scientific shares reached a 25-week high of $588.48, reflecting strong upward momentum despite a recent pullback from earlier session highs.

27.07.2026 г., 18:01 ч. UTC

Thermo Fisher Scientific Inc. shares are lower today amid a broader market reaction to falling oil prices, despite easing geopolitical tensions surrounding Iran.

24.07.2026 г., 19:23 ч. UTC

News
Social Media

Thermo Fisher Scientific shares are lower today despite strong Q2 results and revenue of $11.99 billion. Barclays and Deutsche Bank raised price targets to $650 and $635, respectively.

23.07.2026 г., 23:01 ч. UTC

Thermo Fisher Scientific shares declined in after-market trading, touching a session low before a slight recovery. The stock remains above its 20-day moving average.

22.07.2026 г., 23:02 ч. UTC

Social Media

Thermo Fisher Scientific is set to report earnings, with analysts estimating revenue of $11.71 billion and EPS of $5.72. Shares are higher in after-market trading.

21.07.2026 г., 22:01 ч. UTC

Thermo Fisher Scientific shares are higher in after-market hours, supported by positive market sentiment from strong earnings reports, despite recent lower finishes.

20.07.2026 г., 19:46 ч. UTC

Shares of Thermo Fisher Scientific Inc. are lower today, reflecting routine intraday fluctuations within the asset's one-month trading range.

Сравнение с други в отрасъла

Ценова промяна

Thermo Fisher Scientific Inc Прогноза

Ценова цел

By TipRanks

6.98% нагоре

12-месечна прогноза

Среден 614.41 USD  6.98%

Висок 690 USD

Нисък 520 USD

Според 19 анализатори от Wall Street, предложили 12-месечна ценова цел за Thermo Fisher Scientific Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

19 ratings

14

Купи

5

Задържане

0

Продай

Настроение

By Acuity

66 / 340 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
help-icon Live chat